Cargando…

BNZ-gamma peptide, a potential therapeutic agent in HTLV-1 associated myelopathy

Detalles Bibliográficos
Autores principales:	Massoud, Raya, Enose-Akahata, Yoshimi, Tagaya, Yutaka, Azimi, Nazli, Jacobson, Steven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042232/ http://dx.doi.org/10.1186/1742-4690-11-S1-P14

Ejemplares similares

A multi-cytokine inhibitory peptide (BNZ 132-1) that is a potential therapeutic agent for HAMTSP and other necrotizing diseases.
por: Nata, Toshie, et al.
Publicado: (2015)

Correlation of increased CXCL13 with intrathecal humoral immune responses to HTLV-1 in CSF of patients with HAM/TSP
por: Enose-Akahata, Yoshimi, et al.
Publicado: (2014)

Development of HTLV-1 associated myelopathy/tropical spastic paraparesis in a patient with simian T-lymphotropic virus type 1-like infection.
por: Enose-Akahata, Yoshimi, et al.
Publicado: (2015)

Immunovirological markers in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)
por: Enose-Akahata, Yoshimi, et al.
Publicado: (2019)

Clinical trial of a humanized monoclonal anti-IL15Rβ (CD122), in HTLV-1 associated myelopathy/ tropical spastic paraparesis (HAM/TSP)
por: Massoud, Raya, et al.
Publicado: (2014)

Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals
por: Enose-Akahata, Yoshimi, et al.
Publicado: (2014)

Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals
por: Enose-Akahata, Yoshimi, et al.
Publicado: (2013)

Patterns of spinal cord atrophy in HTLV-1 associated myelopathy/ tropical spastic paraparesis (HAM/TSP)
por: Charlip, Emily, et al.
Publicado: (2015)

Quantifying spinal cord cross-sectional area in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP)
por: Liu, Winston, et al.
Publicado: (2014)

Role of HTLV-1 Tax and HBZ in the Pathogenesis of HAM/TSP
por: Enose-Akahata, Yoshimi, et al.
Publicado: (2017)

T cell receptor repertoire analysis in HTLV-1-associated diseases
por: Clauze, Annaliese, et al.
Publicado: (2022)

Immunophenotyping of cerebrospinal fluid cells in virus-associated neurologic diseases
por: Enose-Akahata, Yoshimi, et al.
Publicado: (2015)

HTLV-1 epigenetic modification of the FoxP3 TSDR in HAM/TSP decreases the functional proliferative suppression of Tregs
por: Anderson, Monique R, et al.
Publicado: (2014)

High Expression of CD244 and SAP Regulated CD8(+) T Cell Responses of Patients with HTLV-I Associated Neurologic Disease
por: Enose-Akahata, Yoshimi, et al.
Publicado: (2009)

Minocycline modulates antigen-specific CTL activity through inactivation of mononuclear phagocytes in patients with HTLV-I associated neurologic disease
por: Enose-Akahata, Yoshimi, et al.
Publicado: (2012)

The contribution of monocytes/macrophages to HTLV-1 infection and persistence
por: de Castro-Amarante, Maria Fernanda, et al.
Publicado: (2014)

IL-2 and IL-15 blockade by BNZ-1, an inhibitor of selective γ-chain cytokines, decreases leukemic T-cell viability
por: Wang, T. Tiffany, et al.
Publicado: (2018)

Treatment of patients with HTLV-1-associated myelopathy with methotrexate
por: Ahmed, S, et al.
Publicado: (2014)

Early diagnosis of HTLV-1-associated myelopathy (HAM/TSP) in HTLV-1 carrier clinic
por: Matsuzaki, Toshio, et al.
Publicado: (2014)

HTLV-1 burden dependent on hijacking monocytes chemotaxis
por: Castro-Amarante, Maria F, et al.
Publicado: (2015)

CXCL10 and neopterin in CSF are candidate prognostic biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Yamano, Yoshihisa, et al.
Publicado: (2014)

Amendment on brain signal intensity on Magnetic Resonance Imaging of asymptomatic HTLV-1 seropositive and HTLV-1 associated myelopathy
por: Bastos, Rafael HC, et al.
Publicado: (2014)

Using the 6 minute walk to investigate endurance in patients with HTLV associated myelopathy
por: Adonis, A, et al.
Publicado: (2014)

A proof of concept study of Infliximab for the treatment of HTLV-1-associated myelopathy
por: Martin, Fabiola, et al.
Publicado: (2014)

The Prevalence and Significance of HTLV-I/II Seroindeterminate Western Blot Patterns
por: Abrams, Anna, et al.
Publicado: (2011)

Sensitivity and specificity of spinal cord Magnetic Resonance Imaging in the diagnosis of HTLV-1 associated myelopathy
por: Romanelli, Luiz CF, et al.
Publicado: (2014)

Biomarker to predict treatment response in patients with HTLV-1 associated myelopathy/Tropical spastic paraparesis (HAM/TSP)
por: Tamaki, Keiko, et al.
Publicado: (2015)

HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)-like disease and toxic epidermal necrolysis (TEN)-like disease in HTLV-1 Tax transgenic mice
por: Ohsugi, Takeo, et al.
Publicado: (2014)

Development of neurologic diseases in a patient with primate T lymphotropic virus type 1 (PTLV-1)
por: Enose-Akahata, Yoshimi, et al.
Publicado: (2016)

HTLV-1 Tax induces Th1 master regulator T-bet and thus IFN-γ in CD4+CCR4+ T-cells of virus-associated myelopathy patients
por: Araya, Natsumi, et al.
Publicado: (2015)

Clinical trial of raltegravir, an integrase inhibitor, in HAM/TSP
por: Enose‐Akahata, Yoshimi, et al.
Publicado: (2021)

Incidence of tropical spastic parapesis/ HTLV-1 associated myelopathy/ (TSP/HAM) in patients followed in a Reference center in Salvador, Brasil
por: Teixeira, Izabel Bou, et al.
Publicado: (2015)

Comparison of walking measures in patients with HTLV-1 Associated Myelopathy
por: Adonis, Adine, et al.
Publicado: (2015)

Deep sequencing analysis of Human T cell lymphotropic virus type 1 (HTLV-1) long terminal repeat (LTR) region of tropical spastic paraparesis (TSP)/HTLV-1 associated myelopathy (HAM) and asymptomatic carriers
por: Rego, Filipe FA, et al.
Publicado: (2014)

Analysis of the association between the sex and disease courses of 132 consequent patients with HTLV-1-associated myelopathy/Tropic spastic paraparesis (HAM/TSP)
por: Matsuura, Eiji, et al.
Publicado: (2015)

Clinical trial of a humanized anti‐IL‐2/IL‐15 receptor β chain in HAM/TSP
por: Enose‐Akahata, Yoshimi, et al.
Publicado: (2019)

Using a sensitive luciferase immunoprecipitation system (LIPS) to detect HTLV-I/II seroindeterminates in Jamaica
por: Akahata, Yoshimi, et al.
Publicado: (2011)

Nation-wide epidemiological study in Japan on HTLV-1 associated myelopathy/tropical spastic paraparesis using HAM-net, a novel patient registration system
por: Coler-Reilly, Ariella LG, et al.
Publicado: (2014)

Reflections on Some of the Exceptional Features of HTLV-1 and HTLV-1 Research: A Perspective
por: Gallo, Robert C., et al.
Publicado: (2022)

Digital droplet PCR for precise quantification of human T-lymphotropic virus 1 proviral loads
por: Brunetto, Giovanna S, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_fjeqd0m617e2o7buc47e9vj34k